EUROCONTROL
APLON transition from non-RVSM to RVSM could be effected PASOS-KAROL-EVORA or APLON depending on destination (this proposal ... (Atlantique Nord).
Taking Context into Account in Conceptual Models Using a Model
1 Aplon France F-62223 Anzin St Aubin
Behind the scenes 2020
Store Nord A/S Denmark ;. Board Member of Gilead. Sciences Inc.
9Len ers du décor 2019
Store Nord A/S Denmark;. Board Member of Gilead. Sciences Inc.
Untitled
Aplon. • Apologic. • Arche-MC2. • ASE2i. • ASS Logicom. • Atlas Tunisie. • Aurior. • Auxitec SNEG (Société Nord Électronique de Gestion).
Behind the scenes
Chairman GN Store Nord. A/S Denmark; Board. Member of Gilead. Sciences Inc.
Mr Per Wold-Olsen* Chairman of MMV Board; former President of
Store Nord A/S Denmark;. Board Member of Gilead. Sciences Inc.
Saksframstilling
Planområde: Planområdet er avgrenset mot fylkesvei (fv.) 557 Ytrebygdsvegen/Fyllingsdalsvegen i sørøst og mot fv. 5184 Grimstadvegen i nord. Mot vest
Directorio internacional International directory Annuaire international
2 Feb 2018 District de Burera/Province du Nord. B.P. 58 KIGALI/MUSANZE ... aplon.regions@aplon.org. / resp. : M. Jacques BELLEC.
ÉTAT DE LA MIGRATION DANS LE MONDE 2018
21 Apr 2017 Jason Aplon Gervais Appave
Mr Per Wold-Olsen*
Chairman of MMV Board;
former President of HumanHealth Intercontinental
Region, Merck & Co.,
Inc., Middle East &
Africa; former Member
of Merck's ManagementCommittee; Chairman GN
Store Nord A/S, Denmark;
Board Member of Gilead
Sciences Inc., USA;
Chair of Oncopeptides AB,
Sweden
Dr David Brandling-
Bennett
Former Senior Advisor,
Malaria, Bill & Melinda
Gates Foundation, USA
Mr Alan Court*
Senior Adviser to the WHO
Ambassador for Global
Strategy, USA; former
Director of the UNICEF
Programme Division in
New York; former Director
of the UNICEF SupplyDivision in Copenhagen
Prof. Sir Michael
Ferguson
Regius Professor
of Life Sciences andAssociate Dean for
Research Strategy,
University of Dundee,
Scotland, UK
Dr Winston Gutteridge
Former Chief, Product
R&D, Special Programme
for Research and Training in Tropical Diseases (TDR),World Health Organization,
Switzerland
Ms Yuli Ismartono
Co-founder and Managing
Editor of AsiaViews;
formerly with TEMPO magazine; Board Member of Nature ResourcesGovernance Institute; the
Coral Triangle Center; the
Prestasi Junior Indonesia;
and the AlternativeAssociation of Southeast
Asian Nations, Indonesia
Mr Gabriel Jaramillo**
Former General Manager
of the Global Fund to FightAIDS, Tuberculosis and
Malaria, Switzerland
Dr Dominique Limet
Former Chief Executive
Of cer, ViiV Healthcare,London, UK
Ms Elizabeth Linder
Executive Director,
Beautiful Destinations,
Senior Consulting Fellow,
Chatham House Director's
Of ce; former Politics &Government Specialist,
Facebook (California and
EMEA region), based
in USA/UKDr Robert Newman
Director, Aspen
Management Partnership
for Health, The AspenInstitute; Former Vice
President and Global
Head, TB Programs,
Johnson & Johnson;
former Director of GlobalMalaria Programme, WHO
Ms Joy Phumaphi
Co-Chair of the
Independent Expert
Review Group for Every
Woman Every Child; Chair
of the Global LeadersCouncil for Reproductive
Health; Executive
Secretary of African
Leaders Malaria Alliance,
USADr David Reddy*
CEO, MMV, Switzerland
Dr Wendy Sanhai
Deloitte Consulting, LLP
(Federal Strategy andOperations); Associate
Professor (adj), Duke
University, School of
Medicine; former Senior
Scienti
c Advisor, Of ce of the Commissioner,US Food and Drug
Administration; former
Senior Director, Global
Regulatory Affairs, GSK,
USADr Dennis Schmatz
Former Vice President and
Head of Tsukuba Research
Institute, Merck-Banyu
Research Laboratories,
Japan (now based in USA)
Ambassador
Dr Konji Sebati
CEO, Innovative
Pharmaceutical
Association of South Africa
(IPASA), Johannesburg,South Africa
Second line left to rightFirst line left to right
* Members of the Audit & Finance Committee ** Chair of the Audit & Finance Committee Medicines for Malaria Venture | Annual report 201952Ms Sylvie Fonteilles-
Drabek
Chair of MMV North
America Board ; General
Counsel and Executive Vice
President, MMV,
Switzerland
Mr Andrea Buscaglia
Chief Financial Of
cer,MMV, Switzerland
Mr Alan Court
Senior Adviser to the WHO,
Ambassador for Global
Strategy, USA; former
Director of the UNICEF
Programme Division in New
York; former Director of the
UNICEF Supply Division in
Copenhagen
Ms Andrea Lucard
Executive Vice President,
Corporate Affairs,
MMV, Switzerland
Dr Dennis Schmatz
Former Vice President and
Head of Tsukuba Research
Institute, Merck-Banyu
Research Laboratories,
Japan (now based in USA)
Dr Stephan Duparc
Co-Chairman MMV Global
Safety Board; Chief Medical
Of cer, MMV, SwitzerlandDr Trevor Gibbs
Co-Chairman MMV Global
Safety Board; Independent
Consultant; former
Senior Vice President,
Pharmacovigilance
& Medical Governance,GSK, UK
Prof. Tim Hammond
Pharmaceutical Preclinical
Safety Consultant, UK
Prof. Pieter Joubert
Clinical Pharmacology
Consultant, UK
Dr John Pears
Director, Woodhouse
Green, UK
Dr John Pottage
Co-Chairman MMV ESAC
(Drug Development); ChiefScienti
c and Medical Of cer,ViiV Healthcare, USA
Dr Michael Witty
Co-Chairman MMV ESAC
(Drug Discovery); DrugDiscovery Consultant and
former Vice President P zerR&D, UK
Dr Aileen Allsop
Former Vice President for
Science Policy, R&D,
AstraZeneca, UK
Prof. Thomas Baillie
Dean Emeritus, School
of Pharmacy, University of Washington, USADr Tesfaye Biftu
Distinguished Professor,
National Institute of
Pharmaceutical Sciences,
Adama Science and
Technology University,
Ethiopia
Sir Simon Campbell
Former Senior Vice President
for WW Discovery, P zer, organic chemist, UKDr Anne Cooper
Programme Director,
Sosei Heptares, UK
Prof. Brian Cox
Professor of Pharmaceutical
Chemistry, University
of Sussex, School of LifeSciences, UK
Ms Delese Mimi Darko
CEO, Safety Monitoring
& Clinical Trials Division, Food and Drugs Authority, GhanaDr Michael Dunne
Chief Medical Of
cer,Durata Therapeutics, USA
Prof. Daniel Goldberg
Professor and Co-Chief,
Division of Infectious
Diseases, Department
of Medicine, WashingtonUniversity, USA
Dr Tim Hammond
Independent Pharmaceutical
Preclinical Safety Consultant
at Preclinical SafetyConsulting Ltd, UK
Dr Monica Hemben
Eimunjeze
Director, Registration
& Regulatory AffairsDirectorate, National Agency
for Food and DrugAdministration and Control,
Nigeria
Dr Laurent Hennequin
Research Director, Galderma
R&D by Nestlé Skin Health/
Galderma R&D, Sophia
Antipolis, France
Prof. Dennis Kyle
Director, Center for Tropical
and Emerging GlobalDiseases, University of
Georgia, USA
Dr Marcus Lacerda
Public Health Specialist,
Fiocruz, Brazil
Prof. John Lambert
quotesdbs_dbs49.pdfusesText_49[PDF] apmep 2012
[PDF] apmep 2015 es
[PDF] apmep 2015 tes
[PDF] apmep 2016
[PDF] apmep 2017
[PDF] apmep 2017 tes
[PDF] apmep bac s
[PDF] apmep bac s maths
[PDF] apmep brevet 2014
[PDF] apmep dnb maths 2017
[PDF] apmep es
[PDF] apmep es 2016
[PDF] apmep fr annee 2014 sujets corriges
[PDF] apmep fr annee 2016 sujets corriges